WENA: anewmeds.com O‘sish sur’atiga tuzatilgan narx-foyda
Anew Medical, Inc. (WENA) miya degenerativ patologiyalari uchun ilg'or gen terapiyasi usullarini ishlab chiqadi. PEG investitsiya jozibadorligi ko'rsatkichi biznesning baholanish dinamikasini namoyish etadi, bunda 0.00 qiymati ushbu metrikaning muvozanatini aks ettiradi. Geopolitik keskinliklar xalqaro sinovlar va reagentlar yetkazib berishni sekinlashtirmoqda. Biroq, intellektual mulkning kengaytirilishi, past sintez xarajatlari va ALS terapiyasining dolzarbligi yuqori o'sish potentsialini ta'minlaydi.
Anew Medical (WENA) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning xususiy kapitalga nisbati Anew Medical, Inc.|WENA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Anew Medical Inc.|WENA - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Anew Medical|WENA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Anew Medical|Tezkor likvidlik ko‘rsatkichi anewmeds.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
WENA - Sof foyda|Prognoz qilingan kelajakdagi foyda Anew Medical, Inc.|WENA - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati anewmeds.com|WENA - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Anew Medical|WENA - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Anew Medical|WENA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi anewmeds.com|WENA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Anew Medical, Inc.
Kompaniyaning umumiy tahlili:anewmeds.com (WENA)
Anew Medical, Inc. (WENA) uchun operatsion risklar va kapital rentabelligi o'rtasidagi muvozanatni topish hozirda to'liq optimallashtirilgan neyro-dori yetkazib berish zanjirlarining samaradorligini tahlil qilishni talab qiladi. peg_co ko'rsatkichi P/E bozor bahosini foyda o'sish sur'atlari bilan solishtiradi: birdan past ko'rsatkich aktivning fundamental jihatdan past baholanganligidan dalolat beradi va joriy kengayish dinamikasi sharoitida biznesning barqarorligini tasdiqlaydi.
Raqobatdosh kompaniyalar
Biogen Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|Regencell Corp (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM: Narx-foyda va o‘sish multiplikatori|acadia-pharm.com (ACAD) - Narx-foyda va o‘sish multiplikatori|XENE (Xenon) - Narx-foyda va o‘sish multiplikatori|Viking Therapeutics Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|Narx-foyda va o‘sish multiplikatori Catalyst Corp (CPRX)|PEG multiplikatori DNLI|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori BHVN (Biohaven)|AMLX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Trevi Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Praxis Corp PRAX|AVXL: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori ceribell.com|PRTA (Prothena Corporation plc) - PEG multiplikatori|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|Narxning foydaga va o‘sish sur’atiga nisbati OMER (omeros.com)|Neurogene Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neumora NMRA|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TVGN|ACOG (Alpha Cognition Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori cogrx.com (CGTX)|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Cassava Sciences Inc|Assertio - Narx-foyda va o‘sish multiplikatori|COYA - Narx-foyda va o‘sish multiplikatori|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ovid Therapeutics Inc.|Acumen Pharmaceuticals, Inc. (ABOS) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CRVO|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|PEG multiplikatori Clene Nanomedicine|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|jupiterneurosciences.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori RLMD (Relmada Therapeutics, Inc.)|Annovis Bio Inc (ANVS) - O‘sish sur’atiga tuzatilgan narx-foyda|GRCE: Narx-foyda va o‘sish multiplikatori|AIFF - PEG multiplikatori|anewmeds.com (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|NeuroSense Therapeutics Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|O‘sish sur’atiga tuzatilgan narx-foyda MetaVia, Inc. MTVA|PEG multiplikatori NRXS|PEG multiplikatori heliusmedical.com (HSDT)|Narxning foydaga va o‘sish sur’atiga nisbati Passage Bio PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Minerva Neurosciences, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Athira Pharma Inc|ADXN (Addex Therapeutics, Ltd.) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Alzamend Neuro|Narx-foyda va o‘sish multiplikatori CYCN|PTIX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|Narx-foyda va o‘sish multiplikatori cortigent.com CRGT|PEG multiplikatori ATXI (Avenue Therapeutics, Inc)|BrainStorm Cell Therapeutics Inc. (BCLI) - O‘sish sur’atiga tuzatilgan narx-foyda|Cara Therapeutics, Inc. - PEG multiplikatori|CHRO (chromocell.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ELYM: PEG multiplikatori|ITCI - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|LBPH (Longboard Pharma) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Marinus Pharma (MRNS)|PEG multiplikatori NKGN|PEG multiplikatori neurobopharma.com (NRBO)|Narxning foydaga va o‘sish sur’atiga nisbati Sage Therapeutics SAGE|Synaptogenix Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|TRVN: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti VIGL (Vigil Neuroscience)|CERE: PEG multiplikatori
